Penfluridol
CAS No. 26864-56-2
Penfluridol ( R-16341 )
产品货号. M13821 CAS No. 26864-56-2
Penfluridol 是一种高效的第一代二苯基丁基哌啶抗精神病药。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 25MG | ¥381 | 有现货 |
|
| 50MG | ¥486 | 有现货 |
|
| 100MG | ¥616 | 有现货 |
|
| 200MG | ¥964 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Penfluridol
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Penfluridol 是一种高效的第一代二苯基丁基哌啶抗精神病药。
-
产品描述Penfluridol is a highly potent, first generation diphenylbutylpiperidine antipsychotic.
-
体外实验Cell Viability Assay Cell Line:Human AML cell lines, HL-60 (FLT3-WT), U937 (FLT3-WT), and MV4–11 (FLT3-ITD) Concentration:1.25, 2.5, 5, 10, 20, 40 μM Incubation Time:24, 48 h Result:Significantly reduced cell viability in a concentration-dependent manner.Apoptosis AnalysisCell Line:HL-60 and U937 cells harboring FLT3-WT Concentration:7.5?μM.Incubation Time:24?h Result:Induced concentration-dependent increases in the sub-G1 population. Triggered caspase-3 activation and corresponding PARP-1 cleavage in concentration- and time-dependent manners.Cell Autophagy Assay Cell Line:U937 and HL-60 cells Concentration:1.25, 2.5, 5, 7.5 μM Incubation Time:24?h Result:5 μM and 7.5?μM respectively induced dominant LC3B-II formation and caspase-3 activation in U937 and HL-60 cells.Western Blot Analysis Cell Line:BMDMs Concentration:1 μM Incubation Time:Pretream for 2 h Result:Obviously inhibited the increased phosphorylation levels of ERK, JNK, and p38 by TNFα (10 ng/mL; 15, 30, 60 min). RT-PCR Cell Line:BMDMs Concentration:1 μM Incubation Time:Pretream for 2 h Result:Inhibited TNFα-induced mRNA expressions of IL-1β, IL-6, IL-17, and NOS2.
-
体内实验Animal Model:DBA/1J male mice aged 10–12 weeks with type II chicken collagen-induced arthritis (CIA) model Dosage:10 mg/kg Administration:Daily oral gavage; from the 18th day after the first immunization Result: Inhibited inflammatory cell infiltration, suppressed pannus formation, and protected articular cartilage from damage. obviously decreased mRNA expressions of CXCL10 and MCP-1 in inflamed joints and statistically reduced production levels of inflammatory cytokines IL-1β and IL-6 in sera.
-
同义词R-16341
-
通路GPCR/G Protein
-
靶点Dopamine Receptor
-
受体Dopamine
-
研究领域Neurological Disease
-
适应症——
化学信息
-
CAS Number26864-56-2
-
分子量523.97
-
分子式C28H27ClF5NO
-
纯度>98% (HPLC)
-
溶解度Ethanol: 100 mg/mL (190.85 mM); DMSO: 100 mg/mL (190.85 mM)
-
SMILESOC1(C2=CC=C(Cl)C(C(F)(F)F)=C2)CCN(CCCC(C3=CC=C(F)C=C3)C4=CC=C(F)C=C4)CC1
-
化学全称1-(4,4-bis(4-fluorophenyl)butyl)-4-(4-chloro-3-(trifluoromethyl)phenyl)piperidin-4-ol
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Creese I, et al. Science, 1976 , 192(4238), 481-483.
产品手册
关联产品
-
N-0500 HCl
N-0500 HCl 是一种非常有效的中枢作用 DA 受体激动剂。 N-0500 HCl 是特异性 [3H]DP_x005f5,6-ADTN 结合的有效置换剂,IC50 为 3nM。
-
UCM-1306
UCM-1306 是一种口服有效的人多巴胺 D1 受体变构调节剂 (PAM)。UCM-1306 增加人和小鼠 D1 受体中的内源性多巴胺 (DA) 最大效应。UCM-1306 不仅可以改善运动症状,还可以解决与长期帕金森病 (PD) 相关的关键共病认知障碍。
-
Rotigotine
多巴胺 D3 受体的非选择性激动剂 (Ki=0.71 nM);对 D3 受体的选择性是 D2、D4 和 D5 受体的 10 倍,对 D3 受体的选择性是 D1 受体的 100 倍。
021-51111890
购物车()
sales@molnova.cn

